Combined treatment with interferon-alpha and ribavirin for subacute sclerosing panencephalitis
- 1 January 2001
- journal article
- case report
- Published by Elsevier BV in Pediatric Neurology
- Vol. 24 (1), 54-59
- https://doi.org/10.1016/s0887-8994(00)00233-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- α-Interferon and isoprinosine in adult-onset subacute sclerosing panencephalitisJournal of the Neurological Sciences, 1999
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virusThe Lancet, 1998
- The cooperative effect of interferon-α and ribavirin on subacute sclerosing panencephalitis (SSPE) virus infections, in vitro and in vivoAntiviral Research, 1998
- Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular alpha-interferonNeurology, 1997
- Subacute sclerosing panencephalitis and chorioretinitisBrain & Development, 1997
- Effect of ribavirin on subacute sclerosing panencephalitis virus infections in hamstersAntimicrobial Agents and Chemotherapy, 1994
- Oral Ribavirin Therapy for Subacute Sclerosing PanencephalitisThe Journal of Infectious Diseases, 1989
- Broad-spectrum synergistic antiviral activity of selenazofurin and ribavirinAntimicrobial Agents and Chemotherapy, 1984
- Long‐term follow‐up of patients with subacute sclerosing panencephalitis treated with inosiplexAnnals of Neurology, 1982
- Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicityNature, 1979